Just ask Rebecca Cherubini. She has been struggling with multiple sclerosis for 15 years.

"I surrendered it to God," she said, "I'm like, 'If this is your will, I would love for You to change it. But if not, ok, then You need to give me the grace to deal.'"

Like most people with MS, Cherubini's came out of the blue when she was young.

"Blurred vision to the point where I started to become nervous about my driving," she recalled. "And then one day I was actually going to work and I pulled off."

In addition to vision problems, other symptoms include fatigue, trouble walking and difficulty thinking.

MS is an autoimmune disease. That's when the body's immune system mistakenly attacks healthy tissue. In the case of MS, the immune system attacks the outer portion of nerves in the brain and the spinal cord. It gets worse over time, and there is no cure.

"I want to be able to drive my kids to soccer," Cherubini said. "I don't want to be debilitated. I don't want to be in a wheelchair."

Now, Cherubini may get her wish. She's one of dozens of MS patients at the Ohio State Medical Center to test a new drug called Ocrelizumab.

The medicine works to stop the cells in the immune system from attacking the central nervous system. It's clearly effective. It's been shown to stop the disease in its tracks—not just the more common "relapsing" form of MS, but also the most aggressive type, called "primary progressive."

"Ocrelizumab was the first medication for primary progressive MS that actually worked," said Dr. Michael Racke, a neurologist at the Ohio State Wexner Medical Center who has been treating MS patients for 30 years.

He says patients call it a game-changer.

"They say, 'You know, I really haven't had any kinds of effects from my MS,' and that's really obviously quite satisfying as an MS physician who can remember the days when we really didn't have anything to treat patients," he said.

Cherubini told Dr. Racke she's delighted the drug has stopped the progression of her disease. (Screengrab: Ocrelizumab/via CBN News)

"I feel normal again. I was telling him, I just feel normal," she said.

Ocrelizumab is not like other MS drugs, such as the pills that have to be taken daily or the shots that come three times a week. It only involves an infusion, which typically lasts four hours, every six months.

"This medicine, I don't have to worry about it," Cherubini said. "I don't have to take it every day. I don't have to worry about ordering it. I don't have to worry about any reactions to it."

Ocrelizumab costs $65,000 a year, which believe it or not, is less than many of the leading MS drugs.

And while this breakthrough can stop the progression of MS, doctors still don't know what causes the disease, so prevention remains a mystery.

"If you look at identical twins, when one twin gets MS, 70 percent of the time the other identical twin, who clearly has the same genetics as their brother or sister, doesn't get MS," explained Dr. Racke.

Since MS is an inflammatory disease, things that cause inflammation, such as obesity, stress and smoking, could factor-in. Early studies show vitamin D might help prevent it.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

The Cross Is 'a Powerful Reminder of the Meaning of Christmas' President Trump Lights the National Christmas Tree and Highlights the Reason for the Season

Evangelist Alveda King: How the 'Grinchy' Press Attacks Christmas

Blockbuster Report: US Adds 266,000 Jobs as Unemployment Hits 50-Year Low 3.5%

Prayer Alert: 4 Dead, Including Gunman, in Florida Naval Base Shooting

Hunter Biden Tied to Ukrainian Who's in Big Trouble: $50,000 a Month for What?

Bloomberg Foundation Has Given More Than $13 Million to Planned Parenthood

Dr. Corinne: Ways to Help Make Your New Year a Positive One

'Jesus Got a Tight Grip on My Soul': Why Putting God in His Life and Music Now Makes Sense to Blake Shelton

Kanye West and Joel Osteen Are Reportedly Planning a Massive Event at Yankee Stadium

'No Matter What Color Your Skin, We Are All Kin': Texas Black Church Hires White Pastor

Botham Jean's Brother Receives Ethical Courage Award for Christ-Like Display of Forgiveness

'Abhorrent': While Nancy Pelosi Moves ahead with 'Articles of Impeachment', Sen. Rand Paul is 'Alarmed at the Abuse of Power by Adam Schiff', It's 'Exactly What He’s Accusing the President of’

No Christians Allowed: Muslim UN Officials Block Syrian Christian Refugees from Getting Help

ISIS Terrorists Captured While Planning Attack in Jerusalem

150,000 Sign Petition for High School Girl Who Wants to Keep Girls Sports For Girls Only

'Tumor Completely Disappeared': Israeli Scientists Discover Molecule That Destroys Pancreatic Cancer Cells; 'Breakthrough Study Shows 90% Reduction'

Former Red Sox All-Star Manny Ramirez Finds God, Enrolls in Seminary

'There's My Aimee Coming Back to Me!': Mac Powell Says 'Prayers Are Being Felt' as Wife Improves after Brain Aneurysm

Mike Bickle: We Are Watching This Biblical Prophecy Unfold Right Before Our Eyes

'An Important Step': French Parliament Passes Resolution that States Anti-Zionism is Anti-Semitism